Literature DB >> 25774550

The effects of short-term and long-term testosterone supplementation on blood viscosity and erythrocyte deformability in healthy adult mice.

Wen Guo1, Eric Bachman, Johannes Vogel, Michelle Li, Liming Peng, Karol Pencina, Carlo Serra, Nicolae L Sandor, Ravi Jasuja, Monty Montano, Shehzad Basaria, Max Gassmann, Shalender Bhasin.   

Abstract

Testosterone treatment induces erythrocytosis that could potentially affect blood viscosity and cardiovascular risk. We thus investigated the effects of testosterone administration on blood viscosity and erythrocyte deformability using mouse models. Blood viscosity, erythrocyte deformability, and hematocrits were measured in normal male and female mice, as well as in females and castrated males after short-term (2 wk) and long-term (5-7 mo) testosterone intervention (50 mg/kg, weekly). Castrated males for long-term intervention were studied in parallel with the normal males to assess the effect of long-term testosterone deprivation. An additional short-term intervention study was conducted in females with a lower testosterone dose (5 mg/kg). Our results indicate no rheological difference among normal males, females, and castrated males at steady-state. Short-term high-dose testosterone increased hematocrit and whole-blood viscosity in both females and castrated males. This effect diminished after long-term treatment, in association with increased erythrocyte deformability in the testosterone-treated mice, suggesting the presence of adaptive mechanism. Considering that cardiovascular events in human trials are seen early after intervention, rheological changes as potential mediator of vascular events warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25774550      PMCID: PMC4398764          DOI: 10.1210/en.2014-1784

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

1.  Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men.

Authors:  Petya Angelova; Albena Momchilova; Diana Petkova; Galya Staneva; Roumen Pankov; Zdravko Kamenov
Journal:  Aging Male       Date:  2012-07-09       Impact factor: 5.892

2.  Adverse events associated with testosterone administration.

Authors:  Shehzad Basaria; Andrea D Coviello; Thomas G Travison; Thomas W Storer; Wildon R Farwell; Alan M Jette; Richard Eder; Sharon Tennstedt; Jagadish Ulloor; Anqi Zhang; Karen Choong; Kishore M Lakshman; Norman A Mazer; Renee Miciek; Joanne Krasnoff; Ayan Elmi; Philip E Knapp; Brad Brooks; Erica Appleman; Sheetal Aggarwal; Geeta Bhasin; Leif Hede-Brierley; Ashmeet Bhatia; Lauren Collins; Nathan LeBrasseur; Louis D Fiore; Shalender Bhasin
Journal:  N Engl J Med       Date:  2010-06-30       Impact factor: 91.245

3.  AMPKalpha1 deletion shortens erythrocyte life span in mice: role of oxidative stress.

Authors:  Shaobin Wang; George L Dale; Ping Song; Benoit Viollet; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

Review 4.  Blood viscosity and thrombosis: clinical considerations.

Authors:  B D Smith; P L La Celle
Journal:  Prog Hemost Thromb       Date:  1982

5.  Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

Authors:  Eric Bachman; Thomas G Travison; Shehzad Basaria; Maithili N Davda; Wen Guo; Michelle Li; John Connor Westfall; Harold Bae; Victor Gordeuk; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-24       Impact factor: 6.053

6.  Effect of testosterone propionate on erythropoiesis after experimental orchiectomy.

Authors:  Delyan P Delev; Delyana P Davcheva; Ilia D Kostadinov; Ivanka I Kostadinova
Journal:  Folia Med (Plovdiv)       Date:  2013 Apr-Jun

Review 7.  Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women.

Authors:  G I Gorodeski
Journal:  Exp Gerontol       Date:  1994 May-Aug       Impact factor: 4.032

8.  Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells.

Authors:  Wen Guo; Eric Bachman; Michelle Li; Cindy N Roy; Jerzy Blusztajn; Siu Wong; Stephen Y Chan; Carlo Serra; Ravi Jasuja; Thomas G Travison; Martina U Muckenthaler; Elizabeta Nemeth; Shalender Bhasin
Journal:  Aging Cell       Date:  2013-02-28       Impact factor: 9.304

9.  Red blood cell aging and risk of cardiovascular diseases.

Authors:  M V Kameneva; K O Garrett; M J Watach; H S Borovetz
Journal:  Clin Hemorheol Microcirc       Date:  1998-04       Impact factor: 2.375

Review 10.  Blood rheology and aging.

Authors:  Michael J Simmonds; Herbert J Meiselman; Oguz K Baskurt
Journal:  J Geriatr Cardiol       Date:  2013-09       Impact factor: 3.327

View more
  8 in total

1.  [Abdominal pain and hypertension in a 55-year-old male patient].

Authors:  T Kofler; F Yueksel; S Dirnhofer; M Y Donath; M Trendelenburg
Journal:  Internist (Berl)       Date:  2017-04       Impact factor: 0.743

2.  Addition of Estradiol to Cross-Sex Testosterone Therapy Reduces Atherosclerosis Plaque Formation in Female ApoE-/- Mice.

Authors:  Laura G Goetz; Ramanaiah Mamillapalli; Cagdas Sahin; Masoumeh Majidi-Zolbin; Guanghao Ge; Arya Mani; Hugh S Taylor
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

3.  Testosterone-dependent sex differences in red blood cell hemolysis in storage, stress, and disease.

Authors:  Tamir Kanias; Derek Sinchar; David Osei-Hwedieh; Jeffrey J Baust; Andrew Jordan; James C Zimring; Hayley R Waterman; Karen S de Wolski; Jason P Acker; Mark T Gladwin
Journal:  Transfusion       Date:  2016-08-09       Impact factor: 3.157

4.  Cross-sex testosterone therapy in ovariectomized mice: addition of low-dose estrogen preserves bone architecture.

Authors:  Teddy G Goetz; Ramanaiah Mamillapalli; Maureen J Devlin; Amy E Robbins; Masoumeh Majidi-Zolbin; Hugh S Taylor
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-08-01       Impact factor: 4.310

5.  Effects of Testosterone on Erythropoiesis in a Female Mouse Model of Anemia of Inflammation.

Authors:  Wen Guo; Paul J Schmidt; Mark D Fleming; Shalender Bhasin
Journal:  Endocrinology       Date:  2016-04-13       Impact factor: 4.736

Review 6.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

7.  Astaxantin and Isoflavones Inhibit Benign Prostatic Hyperplasia in Rats by Reducing Oxidative Stress and Normalizing Ca/Mg Balance.

Authors:  Alexander L Semenov; Ekaterina A Gubareva; Elena D Ermakova; Anastasia A Dorofeeva; Irina A Tumanyan; Ekaterina A Radetskaya; Maria N Yurova; Saied A Aboushanab; Osman N Kanwugu; Elena I Fedoros; Andrey V Panchenko
Journal:  Plants (Basel)       Date:  2021-12-12

8.  Sex-Specific Differences of Adenosine Triphosphate Levels in Red Blood Cells Isolated From ApoE/LDLR Double-Deficient Mice.

Authors:  Fatih Celal Alcicek; Tasnim Mohaissen; Katarzyna Bulat; Jakub Dybas; Ewa Szczesny-Malysiak; Magdalena Kaczmarska; Magdalena Franczyk-Zarow; Renata Kostogrys; Katarzyna M Marzec
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.